About this trial
This study seeks to define what constitutes an MCID and a PASS in patients undergoing a variety of elective major orthopedic surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients aged 18-80 years
ASA class I - III
Primary elective surgery
unilateral total hip replacement
Disqualifiers
Inability to give informed consent
Poor English comprehension
Psychiatric disorders e.g., dementia
Known allergies to morphine / hydromorphone
Trial population
Study patients will be recruited at Toronto Western Hospital
Trial design
Other
Prospective
Treatments tested in this trial
1.Baseline Measurements Before Surgery
Other intervention* Baseline demographic data * Baseline physiological variables (blood pressure, heart rate, respiratory rate, oxygen saturation) * Baseline investigations (hemoglobin, coagulation profile, serum electrolytes) if appropriate. * Preoperative pain state using NRS (0-10) * Preoperative functional state using the QoR-15 questionnaire * Pain expectation - patients will be asked preoperatively with the question "In a scale from 0 to 10 (where 0 = no pain and 10 = worst pain imaginable), what do you consider is an acceptable pain score for your first (and second) day after surgery?... Two weeks after surgery?" * Pain castastrophizing scale
2.Intraoperative Anesthetic Management
Other interventionAll study patients will be managed per routine clinical practice and institutional standard for the performed surgery.
3.Postoperative Analgesic Management
Other interventionpostoperative pain will be managed on the ward using a multimodal analgesic regimen as appropriate. This includes: 1. acetaminophen 650 - 1,000 mg given orally every 6 hours around the clock 2. NSAIDs e.g., celecoxib or other agents given orally around the clock per clinical guideline; omit if contraindicated or per surgeon's preference 3. Opioids e.g., hydromorphone 1-2 mg or oxycodone 15-30 mg given orally every 1-2 hours as required by the patient per standard nurse administered analgesic protocol. 4. In the event of severe pain refractory to the above treatments, the patient will be offered IV opioid e.g., intermittent doses of 0.2-0.4 mg hydromorphone IV every 10 minutes until pain becomes tolerable
4.Postoperative NRS Pain Assessment
Other interventionPain assessment using NRS pain scores (0 = no pain and 10 = worst possible pain) will be performed by an independent research staff, starting immediately in the PACU and serially over the first 48 hours after surgery or until hospital discharge.
5.Postoperative Global Rating Scale (GRS) Pain Assessment
Other interventionAlso, the degree of pain relief after treatment is assessed using a subjective 15-point Global Rating Scale (GRS) as mentioned above (Background). This is performed at the same time of each NRS assessment and a minimum of twice daily
6.Postoperative Patient Acceptable Symptom State (PASS) Assessment for Pain
Other interventionDuring each NRS pain assessment before or after an analgesic intervention on POD 0, 1 and 2, the patient will also be asked this question- ""In your opinion, do you consider your current pain state satisfactory after your operation?" Patients giving a positive response are considered having an acceptable pain state. The PASS is the 75th centile for the pain NRS score in those with a satisfactory pain state.
7.Postoperative Quality of Recovery Assessment
Other interventionThe quality of recovery 15 questionnaire (QoR-15) to measure the dimension of quality of recovery will be administered once in the morning of POD 1 and POD 2. The MCID and PASS for QoR are determined in the same way as for NRS score. The final MCID value will be average of 4 values, 1 generated by the anchor based method and 3 generated by the distribution based method. The PASS for QoR is the 75th centile of the QoR-15 score in those patients who rated their recovery as good.
8.Other Postoperative Assessments
Other interventionAdditionally, opioid related adverse effects e.g., nausea, vomiting, itchiness, constipation, sedation (RASS + Ramsay)/ and respiratory depression will be assessed daily.
Treatment groups
Trial outcomes
Primary outcomes
MCID for NRS pain score after orthopedic surgery
The MCID value represents the change in NRS score after treatment when the patient reports a small improvement of pain relief that corresponds to a GAR score of 2 or 3.
Secondary outcomes
The PASS for NRS pain score after orthopedic surgery
The PASS for NRS pain score after orthopedic surgery
The amount of opioid consumption required to achieve MCID and PASS
The amount of opioid consumption required to achieve MCID and PASS for acute pain after orthopedic surgery.
Quality of recovery
Quality of recovery as assessed using the QoR-15 questionnaire (0-150), higher score means better recovery
The MCID and PASS for QoR-15
The MCID and PASS for QoR-15 (0-150), higher score means better recovery
Sponsors and contacts
Click on the lead sponsor to view all of their trials.